NYSE Insider Trading Activity and SEC Form 4 Filings
NYSE insider trading summary
No open-market insider purchases or sales of Coupang, Inc. (NYSE) have been reported on SEC Form 4 in the past 12 months.
Latest NYSE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 8, 2022 | Greenoaks Capital Partners LLC | Director | Sell | $3.7M (200,000 @ $18.26) |
| Dec 8, 2022 | Neil Mehta | Director | Sell | $3.7M (200,000 @ $18.26) |
| Dec 8, 2022 | Benjamin Peretz | Insider | Sell | $3.7M (200,000 @ $18.26) |
| May 23, 2022 | Lawrence L Gray | Director | Buy | $25K (2,260 @ $11.13) |
| May 11, 2022 | Lawrence L Gray | Director | Buy | $25K (2,235 @ $11.26) |
| May 11, 2022 | Howard Stewart Roth | Director | Buy | $89K (7,782 @ $11.42) |
| May 11, 2022 | Howard Stewart Roth | Director | Buy | $25K (2,218 @ $11.41) |
| May 9, 2022 | Lawrence L Gray | Director | Buy | $50K (4,370 @ $11.50) |
| Oct 30, 2019 | Axar Capital Management L.P. | Director | Buy | $3.9M (3,925,660 @ $1.00) |
| Oct 30, 2019 | Axar GP, LLC | Director | Buy | $3.9M (3,925,660 @ $1.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.